Is C4 Therapeutics, Inc. (CCCC) a Buy, Sell, or Hold?
C4 Therapeutics, Inc.
NASDAQ:CCCC
$3.81 USD
-$0.11 (-2.81%)
- Volume
- 3.05M
- Average Volume
- 3.1M
- Market Capitalization
- $315.57M
- P/E Ratio
- -3.20
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $5.17
- Year Low
- $1.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.00
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-45.6% DOWNSIDE
$7.00 Price Target
UPSIDE/DOWNSIDE HIGH
-45.6% DOWNSIDE
$7.00 Price Target High
UPSIDE/DOWNSIDE LOW
-45.6% DOWNSIDE
$7.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Etzer Darout | $7 | $2.805 | 2026-02-26 12:14 PM | 149.6% |
| Wells Fargo | Derek Archila | $10 | $2.8 | 2025-09-23 06:14 AM | 257.1% |
| Barclays | Etzer Darout | $10 | $3.16 | 2025-09-22 07:14 AM | 216.5% |
| Stephens | Sudan Loganathan | $6 | $3.57 | 2025-09-15 06:23 AM | 68.1% |
| Wells Fargo | Derek Archila | $12 | $4.31 | 2024-12-19 05:39 AM | 178.4% |
| BMO Capital | Etzer Darout | $20 | $6.87 | 2024-09-19 07:45 AM | 191.1% |